WEST BEND, Wis., May 19, 2011 /PRNewswire/ — Leading-edge
Clinical Pharmacology and Cardiac Core Lab provider, Spaulding
Clinical Research, LLC proudly receives the 2011 IQ (Innovation
Quotient) award sponsored by the Marquette University’s Graduate
School of Management and BizTimes Media, a magazine dedicated to
providing Wisconsin business leaders news, analysis and strategic
insights. The revolutionary Spaulding IQ(SM) electrocardiogram was
recognized with nine other award winners for innovative, clever,
and unique products, services, or processes.
The Spaulding IQ is a revolutionary 12-lead electrocardiographic
machine, about the size of a hockey puck, which instead of
keyboards and LCD displays, utilizes a microphone and voice-print
biometrics to identify the patient. IQ is capable of
recording five minutes of data versus the standard 10 seconds of
traditional ECG devices. The Spaulding IQ was designed to be
a cost-effective solution for pharmaceutical clients that have not
centralized ECG drug trial information due to cost and complexity.
The device is part of a total ECG Solution, from Spaulding
Clinical, for clinical trials where cardiac safety data is
required.
Randol Spaulding, CEO and founder of Spaulding Clinical,
commented, “It is difficult to put into words how proud I am of the
teamwork and effort it has taken to move the Spaulding IQ product
from vision through approval. It is a great achievement and
only fitting that we, the makers of IQ, win the IQ Award. We
are honored to be recognized by Marquette and BizTimes Media.”
Spaulding Clinical will be demonstrating the cutting edge
“Spaulding IQ” ECG device and Core ECG Lab Solutions from June 19
– 22, 2011 in booth 1905 at the DIA (Drug Information
Association) meeting in Chicago, IL. To learn more about how
Spaulding can assist with your Clinical Pharmacology programs,
Pharmacokinetic analysis, or ECG Core lab programs, please co
‘/>”/>